| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | CA2362606A1 Therapeutic antimicrobial compositions |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | EP1105738A1 Assays, methods and means for modulating nuclear localisation |
| 06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105467A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105401A1 Phosphoglycolipid and methods for its use |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105378A1 Quinazoline derivatives |
| 06/13/2001 | EP1105133A1 Tricyclic compounds |
| 06/13/2001 | EP1105121A1 Ascorbate-isoquercetin compositions |
| 06/13/2001 | EP1105051A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | DE19959811A1 Production of a stable and sterile skin care composition comprises suspending herbal ingredients and lanolin in ethanol, heating the suspension and removing part of the ethanol by evaporation |
| 06/13/2001 | CN1299407A Vascular endothelial growth factor 2 |
| 06/13/2001 | CN1299350A Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of disease characterized by abnormal cell proliferation |
| 06/13/2001 | CN1299346A Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 06/13/2001 | CN1299291A Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299281A Use of oxazolidinone derivative for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 06/13/2001 | CN1299278A Inhibition of angiogenesis |
| 06/13/2001 | CN1299274A Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 06/13/2001 | CN1298874A Non-ball shaped and non-flake type mercapto pyridine oxide salts and preph. method therefor |
| 06/13/2001 | CN1298732A Ointment for treating burn and scald and its preparing process |
| 06/13/2001 | CN1298725A Ointment for treating burn and scald and its preparing process |
| 06/13/2001 | CN1298723A Liquid medicine for treating scald and its preparing process |
| 06/13/2001 | CN1298713A Face beautifying medicine |
| 06/13/2001 | CN1298712A Plaster for treating arthritis, injury, mastitis, sore and furuncle and its preparing process |
| 06/13/2001 | CN1298711A Process for preparing medical liquid 'Fujinjing' for cleaning skin |
| 06/13/2001 | CN1298701A Compound amino acid composition |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1066958C Anti pruritic aerosol |
| 06/13/2001 | CN1066944C Ointment for burn and scald |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245342 Mixture of oligopeptide, enzyme and carrier |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |
| 06/12/2001 | CA2019957C Heteroarylamino- and heteroaryloxypyridinamines and related compounds, a process for their preparation and their use as dermatological agents |
| 06/12/2001 | CA1341250C Method for inducing biological coverings in wounds |
| 06/11/2001 | WO2001044230A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/11/2001 | CA2393310A1 1-(aminophenyl)-2-pyrrolidones as integrin inhibitors |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040444A2 Method and compositions for producing cell transplants |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | WO2001040114A1 A particle comprising a host lattice and a guest, its preparation and use in ultraviolet light screening compositions |
| 06/07/2001 | WO2001039795A2 Attenuation of fibroblast proliferation |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039771A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 06/07/2001 | WO2001039770A1 USE OF HMG-CoA REDUCTASE INHIBITORS FOR TREATING SEBORRHEA |
| 06/07/2001 | WO2001039739A1 Retinaldehyde combination with antifungal activity |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000074703B1 Therapeutic agent comprising a botulinum neurotoxin |
| 06/07/2001 | DE19952146A1 Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Arylalkanes, aryl alkenes and aryl azaalkane, pharmaceutical compositions containing them and methods for their preparation |
| 06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
| 06/07/2001 | CA2393186A1 Attenuation of fibroblast proliferation |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104425A1 Novel thiazolopyrimidine compounds |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104294A1 Compositions and methods of treating abnormal cell proliferation |
| 06/06/2001 | EP0883695B1 Method and composition for hair removal |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |